Literature DB >> 810019

Latrogenic lipidosis following prolonged intravenous hyperalimentation.

U Freund, Y Krausz, I S Levij, M Eliakim.   

Abstract

Intralipid was used as the main source of calories in the long-term therapy of a patient with severe nutritional failure and cachexia. The treatment was tolerated well for 64 days. The patient died of sepsis after a second therapeutic course which lasted 16 days adn was preceded by an impairment in liver function apparently related to starvation. At autopsy, free fat droplets and extreme foamy swelling of the cytoplasm of the reticuloendothelial cells were found in all examined organs. These findings constitute an unusual example of iatrogenic lipidosis. It is suggested that caution be exerted in the administration of Intralipid to patients with impaired liver function and that serum lipids be maintained regularly during therapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 810019     DOI: 10.1093/ajcn/28.10.1156

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  5 in total

1.  Splenic macrophages in preterm infants: a necropsy study.

Authors:  S Variend; A Drummond; R Coombs
Journal:  J Clin Pathol       Date:  1996-05       Impact factor: 3.411

2.  Splenic lipidosis after administration of intravenous fat emulsions.

Authors:  G B Forbes
Journal:  J Clin Pathol       Date:  1978-08       Impact factor: 3.411

3.  [Fat and renal failure--therapeutic aspects].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-08

4.  Effect of medium/ω-6 long chain triglyceride-based emulsion on leucocyte death and inflammatory gene expression.

Authors:  M F Cury-Boaventura; R Gorjão; T Martins de Lima; J Fiamoncini; A B P Godoy; F C Deschamphs; F G Soriano; R Curi
Journal:  Clin Exp Immunol       Date:  2011-06-17       Impact factor: 4.330

5.  Biochemical and ultra-structural reactions to parenteral nutrition with two different fat emulsions in rats.

Authors:  B Roth; M Ekelund; B G Fan; I Hägerstrand; A Salehi; I Lundquist; P Nilsson-Ehle
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.